Concepedia

Publication | Closed Access

A Randomized Phase 2 Trial of Bevacizumab with or without Daily Low-Dose Interferon Alfa-2b in Metastatic Malignant Melanoma

DOI

142

Citations

33

References

2007

Year

Kimberly A. Varker, Jennifer E. Biber, Cheryl Kefauver, R. Jensen, Amy Lehman, Donn C. Young, Haifeng Wu, Gregory B. Lesinski, Kari Kendra, Helen X. Chen,
Annals of Surgical Oncology

References

YearCitations

Page 1